FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to glioblastoma multiforme diagnostic technique by magnetic resonant tomography (MRT). The technique involves magnetic resonant tomography before and after intravenous administration of a contrast agent. The latter is presented by magnetic nanoparticles of ferric oxide stabilised by a biocompatible polymer and conjugated with monoclonal antibodies to the vascular endothelial growth factor. The particles have a hydrodynamic diameter of less than 150 nm. Magnetic resonant tomography is performed in the Susceptibility Weighted Imaging (SWI) mode providing the susceptibility weighted imaging of the examined region. Glioblastoma multiforme is detected by comparison results of the MR images before and after administration of the contrast agent as shown by low-brightness areas on the MR images.
EFFECT: technique provides higher reliability and information value of diagnosing by increasing a contrast value of the areas corresponding to glioblastoma tissues, its vessels and neoangiogenesis centres.
13 cl, 4 ex, 1 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING A PREPARATION BASED ON MAGNETIC NANOPARTICLES (MNCH) OF IRON OXIDE FOR MRT-DIAGNOSIS OF NEOPLASMS | 2017 |
|
RU2659949C1 |
PREPARATION FOR DIAGNOSING NEW GROWTHS BY MAGNETIC RESONANCE IMAGING | 2019 |
|
RU2723932C1 |
METHOD FOR PREPARING A PREPARATION FOR DIAGNOSING NEW GROWTHS BY MAGNETIC RESONANCE IMAGING | 2019 |
|
RU2723894C1 |
MEANS AND METHOD FOR EARLY EXPERIMENTAL CONTRAST MAGNETIC-RESONANCE TOMOGRAPHIC DETECTION OF MALIGNANT GLIAL TUMORS WITH FEEDING VESSELS | 2016 |
|
RU2655303C2 |
AGENT FOR EARLY CONTRAST DETECTION OF MALIGNANT PROLIFERATION CENTERS WITH FEEDING VESSELS, BOUNDARIES OF DIFFUSE INFILTRATION AND DETERMINATION OF STAGES OF THEIR DEVELOPMENT IN DYNAMICS | 2017 |
|
RU2692579C2 |
MEANS AND METHOD FOR COMBINED CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING IMAGE VISUALIZATION OF BIOMECHANICS OF THE PROCESSES OF INFILTRATION, INVASION AND METASTASIS OF MALIGNANT CELLS | 2020 |
|
RU2761827C1 |
MAGNETIC RESONANT AND RADIOPAQUE CONTRAST AGENT BASED ON COMPLEX FERRIC OXIDE AND METHOD FOR PRODUCING THEREOF | 2009 |
|
RU2419454C1 |
METHOD OF DETECTING TUMOR-FEEDING VESSELS IN EXPERIMENT | 2008 |
|
RU2382596C9 |
FLUORESCENT GLIOMA CELL LINE AND METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2699754C1 |
METHOD FOR DYNAMIC MAGNETIC RESONANCE DIAGNOSTICS OF PELVIC PROLAPSE | 2013 |
|
RU2551186C1 |
Authors
Dates
2014-10-10—Published
2012-12-14—Filed